Hello everybody!

We have been doing IP injections of Tamoxifen to pregnant Cre-loxP mice, for lineage tracing during development.

We usually make a single injection at E11.5 with a dose of Tamoxifen ranging from 1.5 mg to 3.0 mg (depending on the reporter system), combining it with half-dose of Progesteron to counteract the estrogenic effects of Tamoxifen. The embryos are then collected at E17.5.

Our driver CRE strain is crossed with different reporters, like the Brainbow 2.1 (also called Rosa-Confetti), that we never used before in this lab.

Every time that we inject Tamoxifen in the pregnant Confetti females we either have abortions or high mortality of the mothers, in ratios that are not observed with our other reporter strains in use (nlacZ, tdTomato).

Does anybody use Confetti mice and had the same problem? Is it the concentration of Tamoxifen too high? Are they somehow oversensitive?

Thank you!

More Irene Fancello's questions See All
Similar questions and discussions